TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biotechst Lund AB
Closing information (x1000 SEK)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
582
|
717
|
653 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-41
|
17
|
-103 |
| EBITDA |
-42
|
17
|
-103 |
| Total assets |
320
|
341
|
342 |
| Current assets |
320
|
341
|
342 |
| Current liabilities |
111
|
91
|
110 |
| Equity capital |
209
|
250
|
232 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
65.3%
|
73.3%
|
67.8% |
| Turnover per employee |
582
|
717
|
653 |
| Profit as a percentage of turnover |
-7.0%
|
2.4%
|
-15.8% |
| Return on assets (ROA) |
-12.8%
|
5.0%
|
-30.1% |
| Current ratio |
288.3%
|
374.7%
|
310.9% |
| Return on equity (ROE) |
-19.6%
|
6.8%
|
-44.4% |
| Change turnover |
-135
|
64
|
-151 |
| Change turnover % |
-19%
|
10%
|
-19% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.